Oncology Grants
In continuation of CHF’s strong support of canine cancer research, the Oncology Research Program Area remains committed to innovative research that will aid in the discovery of advanced diagnostic technology and therapeutic target identification.
To make sense of the complexity of cancer, new approaches are needed to provide comprehensive characterization of tumors and other canine cancers. These approaches will likely require broad bioinformatic analyses, high throughput methodologies and systems biology tools.
Active Grants:
Previously Awarded Grants:
| 349 | Genetic Epidemiology of Cancer in the Golden Retriever |
| 01054-A | Adult NeurogenesisA Source of Dog Glioblastoma Multiforme (GBMs) Brain Tumor Development |
| 00830-AT | A Pilot Study to Determine the Molecular Characterization of Canine Follicular Thyroid Carcinoma |
| 00896-A | Phase I Clinical Trial and Pharmacokinetics of Intravesical Mytomycin C (MMC) for the Treatment of Canine Transitional Cell Carcinoma (TC) of the Urinary Bladder |
| 00888-A | Generation of Canine Single Chain Fragment Variable Antibody Libraries for the Identification and Targeting of Tumor-Associated Antigens in the Dog |
| 00990-A | Prognostic Indicators for Anal Sac Gland Carcinoma in the English Cocker Spaniel and Preparing to Map Predisposition to this Tumor |
| 00848-A | Evaluation of Neutrophil Function in Treated Tumor-Bearing Dogs |
| 00837-A | Prognostic Significance of Ezrin Expression in Canine High-Grade Soft Tissue Sarcoma |
| 0002646T | Characterization of Receptor Tyrosine Kinase Dysfunction in Malignant Histiocytosis |
| 595 | The Development of a Cellular Delivery System for RNA Interference Targeted to Canine Tumors |
| 0002465T | Identification and Characterization of Genetic Mutations in Canine Mast Cell Tumors |
| 00878-A | MicroRNA Expression in the Domestic Dog and Its Role in Canine Cancer |
| 591 | In Vitro Effects of the Milk Thistle Extract Silibinin in Canine Tumor Cells |
| 00336A | Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog |
| 00336B | Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog |
| 678 | Generation and Analysis of Canine Bone Marrow Derived Mast Cells |
| 00825-A | Microarray Analysis of Immune Responses Elicited by CERT + hGMCSF in Dogs With Advanced Cancer |
| 00718-A | Ras Mutations in Canine Lymphoid and Myeloid Leukemias |
| 00811-A | Gene Expression Profiling of Canine Lymphocytic Leukemia |
| 366 | Molecular Control of COX-2 Expression and Regulation of Prostaglandin Transport in Canine Mammary Tumors |
| 249 | Genomics of Canine Brain Neoplasia |
| 00664-A | Exploration of Alternative Samples for Prognostic Assay of Canine Cancers: Getting the Most Out of Existing Samples and Testing New Ones Collected Without Surgery |
| 00022101T | Development of Anti-Canine Il-2R? Antibodies Using CpG Oligodeoxynucleotide Vaccination |
| 2667 | Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas |
| 00675-A | Evaluation of the Safety of Cisplatin/COX-2 Inhibitor Treatment for Canine Cancer |
The AKC Canine Health Foundation funds research in 23 different Research Program Areas for the health of all dogs. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
